Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors

CRISPR-Cas has revolutionized genetics and extensive efforts have been made to enhance its editing efficiency by developing increasingly more elaborate tools. Here, we evaluate the CRISPR-Cas9 system in <i>Drosophila melanogaster</i> to assess its ability to induce stem cell-derived tumo...

Full description

Bibliographic Details
Main Authors: Shivohum Bahuguna, Siamak Redhai, Jun Zhou, Tianyu Wang, Fillip Port, Michael Boutros
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/11/3156
_version_ 1797510769902878720
author Shivohum Bahuguna
Siamak Redhai
Jun Zhou
Tianyu Wang
Fillip Port
Michael Boutros
author_facet Shivohum Bahuguna
Siamak Redhai
Jun Zhou
Tianyu Wang
Fillip Port
Michael Boutros
author_sort Shivohum Bahuguna
collection DOAJ
description CRISPR-Cas has revolutionized genetics and extensive efforts have been made to enhance its editing efficiency by developing increasingly more elaborate tools. Here, we evaluate the CRISPR-Cas9 system in <i>Drosophila melanogaster</i> to assess its ability to induce stem cell-derived tumors in the intestine. We generated conditional tissue-specific CRISPR knockouts using different Cas9 expression vectors with guide RNAs targeting the BMP, Notch, and JNK pathways in intestinal progenitors such as stem cells (ISCs) and enteroblasts (EBs). Perturbing Notch and BMP signaling increased the proliferation of ISCs/EBs and resulted in the formation of intestinal tumors, albeit with different efficiencies. By assessing both the anterior and posterior regions of the midgut, we observed regional differences in ISC/EB proliferation and tumor formation upon mutagenesis. Surprisingly, high continuous expression of Cas9 in ISCs/EBs blocked age-dependent increase in ISCs/EBs proliferation and when combined with gRNAs targeting tumor suppressors, it prevented tumorigenesis. However, no such effects were seen when temporal parameters of Cas9 were adjusted to regulate its expression levels or with a genetically modified version, which expresses Cas9 at lower levels, suggesting that fine-tuning Cas9 expression is essential to avoid deleterious effects. Our findings suggest that modifications to Cas9 expression results in differences in editing efficiency and careful considerations are required when choosing reagents for CRISPR-Cas9 mutagenesis studies. In summary, <i>Drosophila</i> can serve as a powerful model for context-dependent CRISPR-Cas based perturbations and to test genome-editing systems in vivo.
first_indexed 2024-03-10T05:35:58Z
format Article
id doaj.art-06e7ab93f39740eaa54894aa8ff5c1ce
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T05:35:58Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-06e7ab93f39740eaa54894aa8ff5c1ce2023-11-22T22:52:06ZengMDPI AGCells2073-44092021-11-011011315610.3390/cells10113156Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal TumorsShivohum Bahuguna0Siamak Redhai1Jun Zhou2Tianyu Wang3Fillip Port4Michael Boutros5German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, BioQuant and Medical Faculty Mannheim, Heidelberg University, D-69120 Heidelberg, GermanyGerman Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, BioQuant and Medical Faculty Mannheim, Heidelberg University, D-69120 Heidelberg, GermanyGerman Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, BioQuant and Medical Faculty Mannheim, Heidelberg University, D-69120 Heidelberg, GermanyGerman Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, BioQuant and Medical Faculty Mannheim, Heidelberg University, D-69120 Heidelberg, GermanyGerman Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, BioQuant and Medical Faculty Mannheim, Heidelberg University, D-69120 Heidelberg, GermanyGerman Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, BioQuant and Medical Faculty Mannheim, Heidelberg University, D-69120 Heidelberg, GermanyCRISPR-Cas has revolutionized genetics and extensive efforts have been made to enhance its editing efficiency by developing increasingly more elaborate tools. Here, we evaluate the CRISPR-Cas9 system in <i>Drosophila melanogaster</i> to assess its ability to induce stem cell-derived tumors in the intestine. We generated conditional tissue-specific CRISPR knockouts using different Cas9 expression vectors with guide RNAs targeting the BMP, Notch, and JNK pathways in intestinal progenitors such as stem cells (ISCs) and enteroblasts (EBs). Perturbing Notch and BMP signaling increased the proliferation of ISCs/EBs and resulted in the formation of intestinal tumors, albeit with different efficiencies. By assessing both the anterior and posterior regions of the midgut, we observed regional differences in ISC/EB proliferation and tumor formation upon mutagenesis. Surprisingly, high continuous expression of Cas9 in ISCs/EBs blocked age-dependent increase in ISCs/EBs proliferation and when combined with gRNAs targeting tumor suppressors, it prevented tumorigenesis. However, no such effects were seen when temporal parameters of Cas9 were adjusted to regulate its expression levels or with a genetically modified version, which expresses Cas9 at lower levels, suggesting that fine-tuning Cas9 expression is essential to avoid deleterious effects. Our findings suggest that modifications to Cas9 expression results in differences in editing efficiency and careful considerations are required when choosing reagents for CRISPR-Cas9 mutagenesis studies. In summary, <i>Drosophila</i> can serve as a powerful model for context-dependent CRISPR-Cas based perturbations and to test genome-editing systems in vivo.https://www.mdpi.com/2073-4409/10/11/3156CRISPRCas9tumorsBMPNotchJNK
spellingShingle Shivohum Bahuguna
Siamak Redhai
Jun Zhou
Tianyu Wang
Fillip Port
Michael Boutros
Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
Cells
CRISPR
Cas9
tumors
BMP
Notch
JNK
title Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
title_full Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
title_fullStr Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
title_full_unstemmed Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
title_short Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
title_sort conditional crispr cas genome editing in i drosophila i to generate intestinal tumors
topic CRISPR
Cas9
tumors
BMP
Notch
JNK
url https://www.mdpi.com/2073-4409/10/11/3156
work_keys_str_mv AT shivohumbahuguna conditionalcrisprcasgenomeeditinginidrosophilaitogenerateintestinaltumors
AT siamakredhai conditionalcrisprcasgenomeeditinginidrosophilaitogenerateintestinaltumors
AT junzhou conditionalcrisprcasgenomeeditinginidrosophilaitogenerateintestinaltumors
AT tianyuwang conditionalcrisprcasgenomeeditinginidrosophilaitogenerateintestinaltumors
AT fillipport conditionalcrisprcasgenomeeditinginidrosophilaitogenerateintestinaltumors
AT michaelboutros conditionalcrisprcasgenomeeditinginidrosophilaitogenerateintestinaltumors